Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 13 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

15%

2 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(33.3%)
Phase 4
1(16.7%)
Phase 2
1(16.7%)
Phase 1
1(16.7%)
Phase 3
1(16.7%)
6Total
N/A(2)
Phase 4(1)
Phase 2(1)
Phase 1(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials
NCT06281054Active Not Recruiting

Acute Myocardial Infarction in Cancer Patients

Role: collaborator

NCT06281041Completed

Nationwide Cohort Study of Antiplatelet Agents as Primary Prevention

Role: collaborator

NCT05812963Not ApplicableRecruiting

IVUS Versus FFR for Non-infarct Related Artery Lesions in Patients With Multivessel Disease and Acute MI

Role: collaborator

NCT05590572Phase 1Not Yet Recruiting

A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma

Role: collaborator

NCT03898518Not ApplicableCompleted

The Effects of a Jump Rope Exercise Program on Body Composition and Self-efficacy in Obese Adolescent Girls

Role: collaborator

NCT01480128Unknown

Multicenter Single-port Colectomy RCT

Role: collaborator

NCT01687894Completed

Vasopressin to Prevent Hypotension During Beach Chair Surgery

Role: collaborator

NCT02806102Unknown

CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial Infarction II (COREA-AMI II)

Role: collaborator

NCT02385682Completed

CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial Infarction

Role: collaborator

NCT01238159Phase 2Completed

Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell Lymphoma

Role: collaborator

NCT01315457Completed

Infections Associated With the Use of Alemtuzumab

Role: collaborator

NCT01365572Phase 4Unknown

New Generation Drug Eluting Stent for In-stent Restenosis of Drug Eluting Stent( RESTENT-ISR Trial )

Role: collaborator

NCT01037842Phase 3Completed

Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes Mellitus

Role: collaborator

All 13 trials loaded